← ANALYSTS · TIPRANKS
Andy Chen · Wolfe Research
Hits
67%
37 of 55 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+28.8%
Over a year after the rating, TipRanks’ measure
Our companies rated now
20
Buy / hold / sell: 14 / 5 / 1
Upside of the analyst’s targets
+124.2%
Average over 15 current targets, to the last price
The market’s answer to the ratings
+0.1%
Day-0 move against SPY in the rating’s direction, average over 16 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 12on TipRanks 07:00 | ROIVRoivant Sciences · $25.0B | Downgrade | Hold | — | — | −2.3%next day −3.6% | ↗ |
| Oct 12on TipRanks 05:20 | INSMInsmed · $21.5B | Downgrade | Hold | — | — | −2.0%next day −1.8% | ↗ |
| Sep 10on TipRanks 05:45 | KYMRIWMKymera Therapeutics · $9.0B | Upgrade | Buy | $180 | +71.8% | +2.0%next day −2.6% · 5 days +0.6% | ↗ |
| Aug 4on TipRanks 05:32 | MDGLMadrigal Pharmaceuticals · $10.4B | Upgrade | Buy | $605 | +34.5% | +3.5%next day +1.5% · 5 days +5.6% | ↗ |
| Aug 3on TipRanks Aug 4 11:05 | VRTXQQQSPYVertex Pharmaceuticals · $129B | Reiterated | Buy | $557 | +11.5% | −2.8%next day −0.1% · 5 days +9.3% | ↗ |
| Jul 28on TipRanks 08:30 | SYREIWMSpyre Therapeutics · $7.3B | Downgrade | Hold | — | — | −0.3%next day −0.6% · 5 days +0.9% | ↗ |
| Jul 15on TipRanks 17:25 | NTLAIWMIntellia Therapeutics · $1.6B | Downgrade | Sell | $9.00 | −21.2% | −8.5%next day −3.1% · 5 days −4.7% | ↗ |
| Jul 15on TipRanks 17:20 | IONSIonis Pharmaceuticals · $7.0B | Downgrade | Hold | — | — | +0.4%next day +0.5% · 5 days +3.9% | ↗ |
| Jul 8on TipRanks 17:15 | SRPTIWMSarepta Therapeutics · $1.9B | Upgrade | Buy | $27.00 | +57.9% | +0.7%next day −8.1% · 5 days −15.9% | ↗ |
| Jun 14on TipRanks Jun 15 07:50 | CLDXIWMCelldex · $2.3B | Reiterated | Buy | $51.00 → $44.00−13.7% | +59.8% | +1.0%next day +1.2% · 5 days +5.2% | ↗ |
| Jun 3on TipRanks 13:25 | ABVXAbivax SA Sponsored ADR · $8.6B | Assigned | Buy | $176 → $136−22.7% | +54.3% | +25.0%next day +16.0% · 5 days +12.6% | ↗ |
| Jun 2on TipRanks Jun 3 09:08 | VERAIWMVera Therapeutics · $2.1B | Reiterated | Buy | $88.00 | +215.6% | −8.0%next day +0.7% · 5 days +4.7% | ↗ |
| Apr 8on TipRanks 16:45 | DNTHIWMDianthus Therapeutics · $4.2B | Reiterated | Buy | $98.00 | +35.9% | +4.2%next day −2.0% · 5 days −1.8% | ↗ |
| Apr 8on TipRanks 16:45 | AVTXIWMAvalo Therapeutics · $644M | Initiated | Buy | $48.00 | +325.9% | −2.0%next day −3.8% · 5 days −1.7% | ↗ |
| Apr 8on TipRanks 16:45 | PHVSPharvaris · $2.1B | Initiated | Buy | $42.00 | +51.4% | −2.4%next day −1.6% · 5 days +3.1% | ↗ |
| Apr 8on TipRanks 16:45 | PALIIWMPalisade Bio · $268M | Initiated | Buy | $7.00 | +396.5% | +5.3%next day −8.0% · 5 days +14.5% | ↗ |
| Apr 6on TipRanks Apr 7 08:15 | IMVTIWMImmunovant · $5.8B | Reiterated | Buy | $47.00 | +75.8% | +1.1%next day −1.2% · 5 days −3.2% | ↗ |
| Mar 23on TipRanks 05:50 | MLTXMoonLake Immunotherapeutics · $873M | Upgrade | Buy | $12.00 → $24.00+100.0% | +151.3% | +2.6%next day −0.6% · 5 days +3.9% | ↗ |
| Nov 24on TipRanks 08:20 | ARGXArgenx Se · $51.7B | Downgrade | Hold | — | — | −2.8%next day +0.3% · 5 days −1.0% | ↗ |
| Nov 5on TipRanks 16:40 | IVAInventiva · $877M | Initiated | Buy | $13.00 | +342.2% | +3.0%next day −4.2% · 5 days −8.9% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗